ICD-10 Coding for ESBL-producing E. coli Urinary Tract Infection(A41.51, A41.51B, A41.51M)
Learn about ICD-10 coding for ESBL-producing E. coli UTIs, including primary and ancillary codes, documentation requirements, and coding pitfalls.
Complete code families applicable to ESBL-producing E. coli Urinary Tract Infection
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| N39.0 | Urinary tract infection, site not specified | Use when the site of the UTI is not specified in the documentation. |
|
| B96.20 | Unspecified Escherichia coli as the cause of diseases classified elsewhere | Use to specify E. coli as the causative organism in a UTI. |
|
| Z16.12 | Resistance to extended spectrum beta-lactam antibiotics | Use when ESBL resistance is confirmed in the infection. |
|
| A41.51 | Sepsis due to Escherichia coli | Use when sepsis is documented as due to E. coli. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutESBL-producing E. coli Urinary Tract Infection
Alternative codes to consider when ruling out similar conditions
Use when cystitis is specifically documented.
Documentation & Coding Risks
Avoid these common issues when documenting ESBL-producing E. coli Urinary Tract Infection.
Omitting ESBL resistance documentation
Impact
Clinical: May lead to inappropriate antibiotic selection., Regulatory: Non-compliance with coding standards., Financial: Potential loss of reimbursement for complex cases.
Mitigation
Ensure lab results are reviewed and documented., Educate providers on the importance of resistance documentation.
Using B96.20 with A41.51
Impact
Reimbursement: May lead to incorrect DRG assignment., Compliance: Non-compliance with coding guidelines., Data Quality: Redundant data entry.
Mitigation
Omit B96.20 when A41.51 is used.
Missing Z16.12 with ESBL+ cultures
Impact
Reimbursement: Potential underpayment due to missing complexity., Compliance: Incomplete coding of resistance., Data Quality: Inaccurate representation of resistance patterns.
Mitigation
Add Z16.12 for antimicrobial resistance.
Incomplete resistance coding
Impact
Failure to code ESBL resistance can lead to audit findings.
Mitigation
Implement regular training and audits to ensure compliance.